MD219Z - Method for determining the degree of activity of chronic viral hepatitis C - Google Patents

Method for determining the degree of activity of chronic viral hepatitis C

Info

Publication number
MD219Z
MD219Z MDS20100041A MDS20100041A MD219Z MD 219 Z MD219 Z MD 219Z MD S20100041 A MDS20100041 A MD S20100041A MD S20100041 A MDS20100041 A MD S20100041A MD 219 Z MD219 Z MD 219Z
Authority
MD
Moldova
Prior art keywords
activity
degree
viral hepatitis
chronic viral
determined
Prior art date
Application number
MDS20100041A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Светлана МАЕВ
Влада-Татьяна ДУМБРАВА
Юлианна ЛУПАШКО
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDS20100041A priority Critical patent/MD219Z/en
Publication of MD219Y publication Critical patent/MD219Y/en
Publication of MD219Z publication Critical patent/MD219Z/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to medicine, in particular to hepatology and can be used to determine the degree of activity of chronic viral hepatitis C.Summary of the invention consists in that it is determined the level of alanine aminotranspherase and copper in blood, then it is determined the ratio between the level of copper to the level of alanine aminotranspherase and if the ratio is 0.47...0.55 it is determined a slight degree of activity, if the ratio is 0.34...0.46 it is determined an average degree of activity, and if the ratio is 0.13...0.17 it is determined a high degree of activity of chronic viral hepatitis C.
MDS20100041A 2010-03-05 2010-03-05 Method for determining the degree of activity of chronic viral hepatitis C MD219Z (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDS20100041A MD219Z (en) 2010-03-05 2010-03-05 Method for determining the degree of activity of chronic viral hepatitis C

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDS20100041A MD219Z (en) 2010-03-05 2010-03-05 Method for determining the degree of activity of chronic viral hepatitis C

Publications (2)

Publication Number Publication Date
MD219Y MD219Y (en) 2010-06-30
MD219Z true MD219Z (en) 2011-01-31

Family

ID=45815043

Family Applications (1)

Application Number Title Priority Date Filing Date
MDS20100041A MD219Z (en) 2010-03-05 2010-03-05 Method for determining the degree of activity of chronic viral hepatitis C

Country Status (1)

Country Link
MD (1) MD219Z (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2149G2 (en) * 2001-11-23 2003-10-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Oligonucleotide primer for hepatitis C virus RNA detection
MD2848G2 (en) * 2005-02-22 2006-05-31 ДУМБРАВА Влада-Татиана Method of differential diagnosis of the chronic viral hepatitis C associated with herpetic infection
RU2303261C1 (en) * 2005-12-30 2007-07-20 ГОУ ВПО Смоленская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию Method for estimating chronic hepatitis activity degree
MD3300G2 (en) * 2006-09-28 2007-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Oligonucleotide primer for hepatitis C virus RNA detection
MD34Z5 (en) * 2008-05-20 2010-01-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for diagnosing the viral hepatitis B to babies of up to one year
  • 2010

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2149G2 (en) * 2001-11-23 2003-10-31 Институт Генетики И Физиологии Растений Академии Наук Молдовы Oligonucleotide primer for hepatitis C virus RNA detection
MD2848G2 (en) * 2005-02-22 2006-05-31 ДУМБРАВА Влада-Татиана Method of differential diagnosis of the chronic viral hepatitis C associated with herpetic infection
RU2303261C1 (en) * 2005-12-30 2007-07-20 ГОУ ВПО Смоленская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию Method for estimating chronic hepatitis activity degree
MD3300G2 (en) * 2006-09-28 2007-11-30 Институт Генетики, Физиологии И Защиты Растений Академии Наук Молдовы Oligonucleotide primer for hepatitis C virus RNA detection
MD34Z5 (en) * 2008-05-20 2010-01-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for diagnosing the viral hepatitis B to babies of up to one year

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD975Z (en) * 2015-01-28 2016-07-31 Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова Method for donor blood testing for hepatitis B virus markers

Also Published As

Publication number Publication date
MD219Y (en) 2010-06-30

Similar Documents

Publication Publication Date Title
PH12021550758A1 (en) The use of inhibitors of bruton`s tyrosine kinase (btk)
MX2014005996A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy.
MY178654A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig protein scaffold for use in therapy
IN2014MN01970A (en)
WO2012094550A3 (en) Assays and methods of treatment relating to vitamin d insufficiency
CA2863106A1 (en) Hbv immunocomplexes for response prediction and therapy monitoring of chronic hbv patients
GB201102108D0 (en) Diagnostic method
EP2908555A4 (en) Uncomfortable loudness level estimation system, uncomfortable loudness level estimation processor, uncomfortable loudness level estimation method, and computer program thereof
IN2014DN08385A (en)
MX2015001508A (en) The use of antithrombin in extracorporeal membrane oxygenation.
WO2014179737A3 (en) Assays and methods of treatment relating to vitamin d insufficiency
MD219Z (en) Method for determining the degree of activity of chronic viral hepatitis C
MX2015009606A (en) A natriuretic peptide, a diuretic peptide or a vaso dilatory peptide for use in methods of treating cardiovascular indications.
RU2011105150A (en) METHOD FOR FORECASTING THE FORMATION OF VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS WITH
MD319Y (en) Method for diagnosis of chronic viral hepatitis D and mixed hepatitis B+C
UA62757U (en) Method for prediction of adequacy of program hemodialysis in patients with chronic kidney disorder of v stage
MX2017013384A (en) Compositions comprising adamts13 for use in methods for the recanalization of occluded blood vessels in an infarction.
UA87676U (en) Method for diagnosing mediacalcinosis of artery of foot in syndrome of diabetic foot
UA62791U (en) Method for evaluation of activity of chronic hepatitis c
MD302Z (en) Method for diagnosis of chronic viral hepatites B and C
UA85801U (en) Method for evaluation of effectiveness of treatment of patients with chronic obstructive lund disease combined with metabolic syndrome
苗雄鹰 Expression of ABCG2, SFRP2, BRMS1 and HPA in benign and malignant lesions of the gallbladder and their clinicopathological significances
RU2011102094A (en) METHOD FOR NON-INVASIVE DETERMINATION OF VIRAL LOAD LEVEL IN PATIENTS WITH CHRONIC HEPATITIS WITH
TN2010000442A1 (en) Antiviral therapy
UA56770U (en) method for treatment of chronic hepatitis C

Legal Events

Date Code Title Description
KA4Y Short-term patent lapsed due to non-payment of fees (with right of restoration)